Kelly B. Arnold

Kelly B. Arnold

Auto-generated profile, based on publicly available information

Kelly B. Arnold

Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2015 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
PDF file
LMLindi Masson
Lindi Masson
JPJo-Ann S. Passmore
Jo-Ann S. Passmore
LLLenine J. Liebenberg
Lenine J. Liebenberg
LWLise Werner
Lise Werner
CBCheryl Baxter
Cheryl Baxter
SKSalim S. Abdool Karim
Salim S. Abdool Karim
Background. Women in Africa, especially young women, have very high human immunodeficiency virus (HIV) incidence rates that cannot be fully explained by behavioral risks. We investigated whether genital inflammation influenced HIV acquisition in this group. Methods. Twelve selected cytokines, including 9 inflammatory cytokines and chemokines (interleukin [IL]-1α, IL-1β, IL-6, tumor necrosis factor-α, IL-8, interferon-γ inducible protein-10 [IP-10], monocyte chemoattractant protein-1, macrophage inflammatory protein [MIP]-1α, MIP-1β), hematopoietic IL-7, and granulocyte macrophage colony-stimulating factor, and regulatory IL-10 were measured prior to HIV infection in cervicovaginal lavages from 58 HIV seroconverters and 58 matched uninfected controls and in plasma from a subset of 107 of these women from the Centre for the AIDS Programme of Research in South Africa 004 tenofovir gel trial. Results. HIV seroconversion was associated with raised genital inflammatory cytokines (including chemokines MIP-1α, MIP-1β, and IP-10). The risk of HIV acquisition was significantly higher in women with evidence of genital inflammation, defined by at least 5 of 9 inflammatory cytokines being raised (odds ratio, 3.2; 95% confidence interval, 1.3–7.9; P = .014). Genital cytokine concentrations were persistently raised (for about 1 year before infection), with no readily identifiable cause despite extensive investigation of several potential factors, including sexually transmitted infections and systemic cytokines. Conclusions. Elevated genital concentrations of HIV target cell–recruiting chemokines and a genital inflammatory profile contributes to the high risk of HIV acquisition in these African women.

1 November 2015 in Cell
Verified
Journal Article
Closed access
ACAmy W. Chung
Amy W. Chung
MKManu P. Kumar
Manu P. Kumar
KAKelly B. Arnold
Kelly B. Arnold
WYWen Han Yu
Wen Han Yu
MSMatthew K. Schoen
Matthew K. Schoen
GAGalit Alter
Galit Alter

1 May 2019 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
DODavid N. O’DWyer
David N. O’DWyer
SAShanna L. Ashley
Shanna L. Ashley
SGStephen J. Gurczynski
Stephen J. Gurczynski
MXMeng Xia
Meng Xia
CWCarol Wilke
Carol Wilke
RDRobert P. Dickson
Robert P. Dickson
Rationale: Idiopathic pulmonary fibrosis (IPF) causes considerable global morbidity and mortality, and its mechanisms of disease progression are poorly understood. Recent observational studies have reported associations between lung dysbiosis, mortality, and altered host defense gene expression, supporting a role for lung microbiota in IPF. However, the causal significance of altered lung microbiota in disease progression is undetermined. Objectives: To examine the effect of microbiota on local alveolar inflammation and disease progression using both animal models and human subjects with IPF. Methods: For human studies, we characterized lung microbiota in BAL fluid from 68 patients with IPF. For animal modeling, we used a murine model of pulmonary fibrosis in conventional and germ-free mice. Lung bacteria were characterized using 16S rRNA gene sequencing with novel techniques optimized for low-biomass sample load. Microbiota were correlated with alveolar inflammation, measures of pulmonary fibrosis, and disease progression. Measurements and Main Results: Disruption of the lung microbiome predicts disease progression, correlates with local host inflammation, and participates in disease progression. In patients with IPF, lung bacterial burden predicts fibrosis progression, and microbiota diversity and composition correlate with increased alveolar profibrotic cytokines. In murine models of fibrosis, lung dysbiosis precedes peak lung injury and is persistent. In germ-free animals, the absence of a microbiome protects against mortality. Conclusions: Our results demonstrate that lung microbiota contribute to the progression of IPF. We provide biological plausibility for the hypothesis that lung dysbiosis promotes alveolar inflammation and aberrant repair. Manipulation of lung microbiota may represent a novel target for the treatment of IPF.

1 January 2016 in Mucosal Immunology
Verified
Journal Article
Closed access
PDF file
KAKelly B Arnold
Kelly B Arnold
ABAdam Burgener
Adam Burgener
KBKenzie Birse
Kenzie Birse
LRLaura Romas
Laura Romas
LDLaura J Dunphy
Laura J Dunphy
LMLyle R McKinnon
Lyle R McKinnon

1 April 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
KSKevin J. Selva
Kevin J. Selva
Carolien Emma van de SandtCarolien Emma van de Sandt
Carolien Emma van de Sandt
MLMelissa M. Lemke
Melissa M. Lemke
CLChristina Y. Lee
Christina Y. Lee
SSSuzanne K. Shoffner
Suzanne K. Shoffner
ACAmy W. Chung
Amy W. Chung
The hallmarks of COVID-19 are higher pathogenicity and mortality in the elderly compared to children. Examining baseline SARS-CoV-2 cross-reactive immunological responses, induced by circulating human coronaviruses (hCoVs), is needed to understand such divergent clinical outcomes. Here we show analysis of coronavirus antibody responses of pre-pandemic healthy children (n = 89), adults (n = 98), elderly (n = 57), and COVID-19 patients (n = 50) by systems serology. Moderate levels of cross-reactive, but non-neutralizing, SARS-CoV-2 antibodies are detected in pre-pandemic healthy individuals. SARS-CoV-2 antigen-specific Fcγ receptor binding accurately distinguishes COVID-19 patients from healthy individuals, suggesting that SARS-CoV-2 infection induces qualitative changes to antibody Fc, enhancing Fcγ receptor engagement. Higher cross-reactive SARS-CoV-2 IgA and IgG are observed in healthy elderly, while healthy children display elevated SARS-CoV-2 IgM, suggesting that children have fewer hCoV exposures, resulting in less-experienced but more polyreactive humoral immunity. Age-dependent analysis of COVID-19 patients, confirms elevated class-switched antibodies in elderly, while children have stronger Fc responses which we demonstrate are functionally different. These insights will inform COVID-19 vaccination strategies, improved serological diagnostics and therapeutics.

11 September 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
DMDaniel L. Matera
Daniel L. Matera
KDKatarina M. DiLillo
Katarina M. DiLillo
MSMakenzee R. Smith
Makenzee R. Smith
CDChristopher D. Davidson
Christopher D. Davidson
RPRitika Parikh
Ritika Parikh
Brendon M. BakerBrendon M. Baker
Brendon M. Baker
Tissue-engineered fibrosis model highlights distinct cell responses to matrix stiffness and drug treatment in 2D versus 3D.